Engaging Patients in Real-World Evidence: An Atrial Fibrillation Patient Advisory Board Case Example
Patient
.
2021 Mar;14(2):295-300.
doi: 10.1007/s40271-020-00479-8.
Epub 2020 Dec 23.
Authors
Elisabeth M Oehrlein
1
,
Xuemei Luo
2
,
Mirko Savone
3
,
Trudie Lobban
4
,
Amiee Kang
5
,
Brian Lee
5
,
Rex Gale
6
,
Silke Schoch
7
,
Eleanor Perfetto
7
8
Affiliations
1
National Health Council, 1730 M St, Suite 500, Washington, DC, USA.
[email protected]
.
2
Pfizer, Inc, Health Economics and Outcomes Research, Groton, CT, USA.
3
Pfizer, Inc., New York, NY, USA.
4
Heart Rhythm Alliance, Arrhythmia Alliance, PO Box 5507, Hilton Head Island, SC, 29938, USA.
5
Bristol-Myers Squibb Company, 3401 Princeton Pike, Lawrence Township, NJ, 08648, USA.
6
Board Member-Arrhythmia Alliance, P O Box 5507, Hilton Head Island, SC, 29938, USA.
7
National Health Council, 1730 M St, Suite 500, Washington, DC, USA.
8
Department Pharmaceutical Health Services Research, University of Maryland Baltimore, 220 Arch Street 12th floor, Baltimore, MD, 21201, USA.
PMID:
33355917
PMCID:
PMC7884300
DOI:
10.1007/s40271-020-00479-8
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Atrial Fibrillation*
Humans
Treatment Outcome